Transdermal Drug Delivery Systems

decision foresight.png

Global Transdermal Drug Delivery Systems Market Size, Share, Growth, Industry Trends and Forecast 2020-2030


Transdermal drug delivery systems transport drugs through the skin to guarantee a systemic drug circulation and maintain clinically effective concentrations at a predetermined rate over an estimated timeline. The drug or medicine is generally applied in the form of a plaster, patch, or ointment such that the drug is gradually absorbed into the systemic circulation. Transdermal drug delivery systems comprise of five key components mainly the drug, polymer matrix, permeation enhancers, adhesives, and backing layers. This system of drug transfer is easy-to-use and more convenient than conventional drug administration systems. The global transdermal drug delivery systems market is accounted approximate USD 36767.1 million in 2020 and it is expected to reach approximate USD 92795.1 million by 2030 with a CAGR of 9.7% during forecast period.    

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020201

Market Dynamics and Factors:

Rising geriatric population along with growth in chronic diseases across the globe are the major factors driving the transdermal drug delivery systems market. For instance, according to World Health Organisation in 2017, there are about 422 million people suffering from diabetes across the globe. Furthermore, the advantage of transdermal drug delivery system over other conventional drug delivery system is also attributing towards the growth of the market. For instance, there are certain limitations linked with oral drug delivery, such as incomplete delivery of drugs to the target site due to unexpected gastrointestinal absorption. The injectable drug delivery system is an effective mode but the pain associated with injections limits its usage among many individuals. However, certain factors like high cost of transdermal drug delivery system; natural limits of drug entry due to skin’s permeability; and irritation are going to restrain the market growth of transdermal drug delivery systems.   

Market Segmentation:

  • Global Transdermal Drug Delivery Systems Market – By Type

    • Transdermal Patches

    • Transdermal Semisolids

  • Global Transdermal Drug Delivery Systems Market – By Application

    • Pain Management

    • Hormonal Applications

    • Central Nervous System Disorder

    • Cardiovascular Diseases

    • Others

  • Global Transdermal Drug Delivery Systems Market – By End-Users

    • Hospitals

    • Clinics

    • Home Care

    • Others

  • Global Transdermal Drug Delivery Systems Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020201

Geographic Analysis:

North America is expected to dominate the global transdermal drug delivery system in terms of market share during the forecast period. The rising occurrence of chronic health disorders such as cardiovascular diseases, diabetes, and neurological disorders is increasing the demand for transdermal drug delivery systems in the region. For instance, according to American Diabetes Association in 2017, more than 1.5 million Americans are diagnosed with diabetes every year. Europe is expected to be the second most dominating market for transdermal drug delivery systems during the forecast period in terms of market share. Rising usage of vapour patch to reduce smoking, and increasing emphasis of patients for simple drug delivery systems are certain factors enhancing the market growth in the region. The Asia Pacific region is anticipated to be the fastest growing market for transdermal drug delivery systems during the forecast period. The huge patient pool of chronic diseases; growing healthcare infrastructure; and rising investments by key players in the APAC region are some factors attributing for the market growth of transdermal drug delivery systems in the region.

Competitive Scenario:

The key players operating in the global transdermal drug delivery systems market are –

Johnson & Johnson, GlaxoSmithKline, Novartis AG, Bayer AG, Acrux Limited, Hisamitsu Pharmaceutical Co. Inc., Allergan Plc., Pfizer, Actelion Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020201 

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Transdermal Drug Delivery Systems industry, although key threats, opportunities and disruptive technologies that could shape the Global Transdermal Drug Delivery Systems Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Transdermal Drug Delivery Systems Market most.

  4. The data analysis present in the Global Transdermal Drug Delivery Systems Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Transdermal Drug Delivery Systems Market business.

The 2021 Annual Global Transdermal Drug Delivery Systems Market offers:

  • 100+ charts exploring and analysing the Global Transdermal Drug Delivery Systems Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Transdermal Drug Delivery Systems Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020201 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/


 

Comments

Post a Comment

Popular posts from this blog

Digital Pathology

Image
  Global Digital Pathology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Global Digital Pathology Market accounted USD 721.7 million in 2020 and is anticipated to reach USD 2281.7469 million by 2030, at a CAGR of 12.2% during the forecast period. It is an innovation predominantly committed to minimize laboratory expenses, increase operational efficiency, improving treatment decisions and patient care, and improved overall productivity. This technique incorporates the management, acquisition, sharing and interpretation of pathology information — which include slides and data — in a digital environment. Digital slides are produced when glass slides are apprehended with a scanning device, to deliver a high-resolution digital image that can be observed on a computer screen or mobile device. Virtual microscopy is a part of the market which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer m...
Read more

Global Antisense And RNAi Therapeutics Market

Image
  Global Antisense And RNAi Therapeutics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Antisense and RNAi therapeutics are therapeutic treatments having the potential to treat diseases such as chronic liver and cardiovascular diseases, and other rare diseases. Antisense RNAi was the largest technology segment in 2018 due to technological advancement in the healthcare sector. Antisense technology is a method that can stop protein production. Antisense technology can be used to design new therapeutics for certain new diseases. The principle behind is antisense nucleic acid sequence base pairs with complementary sense RNA strand and avoids from being translated into a protein. Based on the triggering of the RNA molecules this technology is segmented into siRNA and miRNA. Antisense and RNAi therapeutics services are applicable in the treatment of a wide range of diseases that target nucleic acid and affect the cell growth cycle. miRNA has the ability to restore gen...
Read more

Regenerative Therapies

Image
  Global Regenerative Therapies Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030 The Global regenerative therapies market held USD 8.5 billion in 2020 and is to grow with a CAGR of 15.7% from 2020-2030. Regenerative medicine is medicine principle that focuses on the replacement of tissues, human cells and organs in order to restore normal functionality. Regenerative medicine aims to renew or replace cells in the damaged and unfitting tissue or organ of human beings. The body's own cells can be encouraged to cure, or a patient with laboratories-grown cells and tissues can be therapied. It can treat incurable chronic disorders and conditions such as Alzheimer's disease, Parkinson's disease, diabetes, cardiac illness, kidney failure, osteoporosis and injuries to the spinal cord, etc. Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Tabl...
Read more